Home » Topics » BioWorld

BioWorld
RSS

XOMA PREDICTS BREAK-EVEN RESULTS IN 1991

Jan. 8, 1991

AMGEN EXPECTS NEUPOGEN TO GET NOD

Jan. 8, 1991

GENENTECH SIGNS $15M PACT WITH GLYCOMED

Jan. 8, 1991

HAMBRECHT AND QUIST CONFERENCE BRIEFS:

Jan. 8, 1991

NEWS BRIEFS

Jan. 8, 1991

PLAY THE MARKET WITH BIOWORLD'S 'MONEY'

Jan. 7, 1991

NEWS BRIEFS

Jan. 7, 1991

EARNINGS REPORTS

Jan. 7, 1991

APPOINTMENTS AND ADVANCEMENTS

Jan. 7, 1991

JOURNAL SCAN

Jan. 7, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.